REBOA: Is This Shiny Toy Losing It’s Luster?

REBOA has been around in one form or another for decades. It was first used by vascular surgeons to gain control of pesky bleeding. It began its move into the trauma arena in 2011 with experimental use for major hemorrhage control in swine. After successful trials, it made the jump to humans in 2015.

Its use exploded over the following decade, peaking at 127 publications in 2021.

Trauma centers across the US were clamoring to be the first in their neighborhoods to get it. However, there were a few problems:

  • It was not clear which patients would benefit from its usage.
  • The number of patients who had significant bleeding below the diaphragm or from pelvic fractures was generally low in all but the busiest centers.
  • There were significant vascular complications with disturbing frequency.

So what have we learned after about 2,000 published papers? The Eastern Association for the Surgery of Trauma (EAST) recently published another practice guideline to help us make good decisions. They conducted a systematic review and meta-analysis of 31 studies to answer six questions about REBOA use.

Here are the questions and their answers:

  1. In hemodynamically unstable trauma patients with suspected sub-diaphragmatic bleeding, should REBOA vs. no REBOA be performed before definitive hemostatic procedures to reduce time to definitive intervention, blood transfusion requirements, and mortality?  (12 studies) Unfortunately, the evidence was of low quality due to selection bias, heterogeneity across studies, and wide confidence intervals resulting from small sample sizes. The review committee gave a conditional recommendation against using REBOA for these patients. The only randomized clinical trial available actually showed increased mortality in the REBOA group. The quality of the other studies was not enough to offset this.
  2. In hemodynamically unstable trauma patients with suspected pelvic fractures, should REBOA versus no REBOA be performed, before definitive hemostatic procedures, to decrease time to definitive intervention, blood transfusion requirements, and mortality? (11 studies) Once again, the quality of the papers reviewed was low. Similar to the question above, the committee gave a conditional recommendation against using REBOA in these patients.
  3. In trauma patients with cardiac arrest OR impending cardiac
    arrest due to suspected subdiaphragmatic bleeding, should REBOA versus resuscitative thoracotomy be utilized to increase the rate of return of spontaneous circulation (ROSC), decrease time to aortic occlusion, and decrease mortality?
    (13 studies) Although patients receiving REBOA had 4x lower mortality, the quality and confounding factors were so significant that the committee could not make a recommendation for or against REBOA use in this population.
  4. In trauma patients with cardiac arrest due to suspected subdiaphragmatic bleeding, should REBOA versus resuscitative thoracotomy be utilized to increase the rate of ROSC, decrease time to the aortic occlusion, and decrease mortality? (7 papers) This is a bit of slicing and dicing of the question. It applies only to patients in cardiac arrest and excludes those in whom it is “impending.” This reduced confounding data and demonstrated an identifiable decrease in mortality by more than half. Despite poor-quality data, the committee conditionally recommended the use of REBOA in this population.
  5. In hemodynamically unstable patients with subdiaphragmatic
    bleeding of non-traumatic etiology, should REBOA versus no
    REBOA be used prior to definitive hemostatic procedures, to decrease blood transfusion requirements and mortality?
    (1 paper) Given that there was only one paper and the quality of the data for analysis was low, the committee could not recommend for or against REBOA use in this group.
  6. In hemodynamically stable patients with anticipated subdiaphragmatic bleeding due to placenta accreta syndrome (PAS), should REBOA vs no REBOA be performed prophylactically, prior to definitive hemostatic procedures, to decrease blood transfusion requirements and blood loss? (12 studies) The number of studies and their quality were very low, but REBOA use decreased packed red cell transfusion requirements by 3 units. The committee conditionally recommended for the use of REBOA for bleeding from placenta accreta. However, they cautioned about the possibility of complications from the procedure.

Bottom line: These recommendations are moving away from recommending REBOA for all cases with severe subdiaphragmatic or pelvic bleeding. In fact, they recommend its use only for patients actually in arrest or with placenta accreta. This last situation is very uncommon (approximately 1 in 400-500 pregnancies) but is increasing slowly over time. About half of these cases result in significant hemorrhage. 

It’s time for most centers to start revising their REBOA protocols (if you have them). For high-volume centers, continue publishing your work to help us fine-tune the use of this valuable, but not invaluable, tool!

Reference: Resuscitative Endovascular Balloon Occlusion of the Aorta in surgical and trauma patients: a systematic review, meta-analysis and practice management guideline from the Eastern Association for the Surgery of Trauma. Trauma Surg Acute Care Open. 2025 Mar 28;10(1):e001730. doi: 10.1136/tsaco-2024-001730. PMID: 40166770; PMCID: PMC11956280.

Autopsy Reports and Performance Improvement

Autopsy reports have traditionally been used as part of the trauma performance improvement (PI) process. They are typically a tool to help determine opportunities for improvement when reviewing mortality cases where the etiology is not clear. Deaths that occur immediately prior to arrival or in the ED are typically those in which most questions arise.

The American College of Surgeons Trauma Verification Program previously included a question on what percentage of deaths at a trauma center undergo autopsy, but this was discontinued with the 2022 standards. Low rates were usually discussed further, and strategies for improving them were considered. But even though autopsy review rates are no longer scrutinized, are they really that helpful?

A total of 434 trauma fatalities in one state over a one year period were reviewed by a multidisciplinary committee and preventability of death was determined. Changes in preventability and diagnosis were noted after autopsy results were available.

Here are the factoids:

  • The autopsy rate was 83% for prehospital deaths and 37% for in-hospital deaths
  • Only 69% were complete autopsies; the remainder were limited internal or external only exams
  • Addition of autopsy information changed the preventability determination in 2 prehospital deaths and 1 in-hospital death (1%)
  • In contrast to this number, it changed the cause of death in about 40% of cases, mostly in the prehospital deaths

Bottom line: From a purely numerical performance improvement standpoint, autopsy did not appear to add much to determining preventability of death. It may modify the cause of death, which could be of interest to law enforcement personnel. And it may modify some of the diagnoses recorded in the trauma registry.

Anecdotally, I have received reports that opened my eyes to significant opportunities for improvement. I would still recommend obtaining the reports and performing at least a cursory review for their educational value, especially for those of you who are part of residency training programs.

Reference: Dead men tell no tales: analysis of the utility of autopsy reports in trauma system performance improvement activities. J Trauma 73(3): 587-590, 2012.

Betteridge’s Law: Reading The Literature

I’ve always had a diverse set of interests spanning many, many disciplines beyond medicine and trauma care. But I’m always thinking about how I can apply concepts and facts learned in those other topic areas to my main area of interest.

I recently came across an interesting concept while browsing articles in the mainstream media. Ever notice how often you see medically focused pieces with titles phrased as questions? Why do they do this all the time?

It turns out, there is a reason for it. It all boils down to something called Betteridge’s Law. Ian Betteridge was a British technology journalist who commented on a TechCrunch article in 2009. He observed the following:

This story is a great demonstration of my maxim that any headline which ends in a question mark can be answered by the word “no”. The reason why journalists use that style of headline is that they know the story is probably bullshit, and don’t actually have the sources and facts to back it up, but still want to run it.

Betteridge was not necessarily the inventor of this concept. It appears to have been initially published in a 1991 compilation of Murphy’s Law variants. It was referred to as Davis’ Law, though no explanation of who Davis was was provided.

A more tame version of Betteridge’s Law is, “Any headline that ends in a question mark can be answered by the word no.” If the author were more confident of the answer, they would have written it as an assertion, not a question.

So I was curious. Is this true of article titles in medical journals, too? I randomly selected a few articles from the Journal of Trauma over the past 15 years. Here they are:

  • Does computed tomography scan add any diagnostic value to the evaluation of stab wounds of the anterior abdominal wall? A systematic review and meta-analysis. Journal of Trauma and Acute Care Surgery 88(4):p 572-576, April 2020. | DOI: 10.1097/TA.0000000000002587
  • Can we ever stop worrying about venous thromboembolism after trauma?. Journal of Trauma and Acute Care Surgery 78(3):p 475-481, March 2015. | DOI: 10.1097/TA.0000000000000556
  • Is Early Reimaging CT Scan Necessary in Patients With Grades III and IV Renal Trauma Under Conservative Treatment?. The Journal of Trauma: Injury, Infection, and Critical Care 68(1):p 9-12, January 2010. | DOI: 10.1097/TA.0b013e3181ad5835

After reading the papers, the answer to each question was indeed no! Now, I am not suggesting that the answer is always no for every title phrased as a question, or that, as Betteridge said, “the story is probably bullshit.” But there does seem to be a significant correlation in our literature.

Bottom line: When doing your journal reading, look at the article title to see if it is phrased as a question. If so, consider that it might have already answered itself, and you may not need to spend as much time reading it in detail!

Practice Guidelines: The Holdouts

I’ve spent several posts discussing the whys and hows of developing clinical practice guidelines. But no matter how well you craft them and how much buy-in you get from potential users, there will always be a few holdouts.

In my experience, these recalcitrants fall into two general groups: the “I can do it better” group and the “I don’t like cookbooks” group. Let’s examine each one and see what can be done about them.

“I can do it better”

This group is implying that their experience and expertise exceed that of the rest of us “average” trauma professionals. They believe that their experience managing an unknown number of similar cases elevates their clinical acumen above all others. In a way, they imply that anyone who disagrees with their management is wrong.

Unfortunately, in medical care, there are very few absolute rights and wrongs, just a continuum of shades of gray. No clinician has seen enough cases to figure out how to manage the edge cases and the patients whose conditions are getting close to those very gray edges. To claim that one’s own experience allows better judgment than the collective experience of hundreds or thousands of colleagues borders on narcissism.

Unfortunately, it is extremely difficult to change anyone else’s mind. We all have cognitive biases in place to protect us from having to admit we were wrong about something. Confronting someone resistant with a pile of facts and justifications will only cause them to double down in their convictions that they are right.

There is no easy solution for such cases. The most effective technique is to slowly build buy-in from all their peers, so they end up as the last man/woman out. Over time, they may slowly recognize that the care provided by their peers is working at least as well, if not better, than theirs. If it is possible to include time and work-savers in the guideline, this may also help win the outlier over.

“I don’t like cookbook medicine”

In the early days of aviation, there were occasional horrific accidents, such as forgetting to lower the landing gear before touchdown. These occurred because the pilots were essentially “flying by the seat of their pants” and randomly using a mental list of tasks as they prepared for landing. The occasional mistake was inevitable.

However, this changed once the concept of checklists was introduced. If you ever watch a cockpit video during the approach phase of a commercial aircraft landing, you will see both pilots step through complex checklists in order and receive verification of each step from each other. When was the last time you remember a commercial aircraft landing with its gear up?

Practice guidelines are essentially a checklist of inputs to be evaluated and orders to be placed. They have been developed using sound, evidence-informed reasoning, so they are the best they can be until better research becomes available. But in medicine, as in aviation, there are a few rare events or conditions that were not or could not be considered when the guidelines were developed.

Fortunately, these edge cases make up only a few percent of the cases we encounter. The “cookbook approach,” or “checklist approach” as I like to call it, actually works well most of the time.

Here’s what you should do when faced with the “cookbook” objection.

  1. Include a phrase similar to the following in every guideline you publish: “These guidelines are not a replacement for clinical judgment and may be altered by a senior clinician as appropriate.”
  2. Explain to everyone that they are welcome to vary from the guidelines when they believe it is warranted, but they must document their rationale in a progress note in the chart. Inform everyone that if the rationale is sound, it may be used to revise and improve the guideline. But if the rationale is either unsound or undocumented, the case will definitely be discussed at the next multidisciplinary trauma PI committee meeting.

 

Guidelines vs Protocols / Evidence-Based vs Evidence Informed

In my last two posts, I reviewed the importance of having practice guidelines at your trauma center and gave some pointers on how to develop them. Today I’ll give you my take on the nomenclature and the evidence they are based on.

There are lots of names given to what we have come to know as clinical practice guidelines. You’ve heard many of them. Guidelines. Pathways. Protocols. What’s the difference?

Unfortunately, there are no real and solid definitions of these terms when used for clinical care. So here is my take on them:

  • Guideline. Guidelines are general principles that guide management. These are best illustrated by the practice guidelines published annually by the Eastern Association for the Surgery of Trauma (EAST). Each EAST guideline tackles a specific clinical problem, like DVT or blunt cardiac injury. It presents a series of clinical questions regarding the topic, such as “which is better, unfractionated heparin or low molecular weight heparin.” The pertinent literature is reviewed and its overall quality is judged. Then the questions are answered and the confidence in that answer is given, based on the strength of the research (strongly recommended vs recommended vs conditionally recommended, etc.). So in reading the guideline you may see that the use of low molecular weight heparin is recommended over unfractionated heparin in certain circumstances.
  • Protocol. A protocol is a description of very specific behaviors that are followed in certain situations. The behaviors can be described either in a list format (such as that followed in some type of formal ceremony) or in a flow diagram which is best used in clinical care.
  • Pathway. In my mind, this falls somewhere between the two extremes of guideline and protocol. It is more specific than a guideline, but less so than a protocol.

In clinical care, specifics are important. Without specificity, there is still much opportunity for variation in care, which defeats the purpose. The EAST guideline described above paints some broad strokes about clinical care, but there are huge gaps between the questions answered that need answers to provide actual patient care.

So although we (and I) tend to call these documents clinical practice guidelines, they are really clinical care protocols. They should be written in such a way that care can be provided in an “if this, then that” manner. If any kind of hedging language is used, like the word “consider”, the document is only a guideline. And this fact becomes extremely important when your trauma PI program tries to monitor for compliance. It is immediately obvious when someone deviates from the protocol, while a savvy clinician can always claim that they “considered” the desired course of action before they chose their own way using a guideline.

Now, what about evidence-based guidelines? Isn’t that what we all strive for? First of all, they’re not guidelines, remember. They are protocols. And second, there is no area of medicine where the research is so detailed that you know what to do down to specific blood draw times, vital sign monitoring, or operative techniques. There is still plenty of room for debate even in something as simple as chest tube removal. Water seal or not? How long until you get a followup x-ray? The possibilities never end.

So it’s basically impossible to develop anything that is completely evidence-based. We always have to take the best evidence and supplement it with clinical experience and judgement. The latter is what we use to fill in all the blanks in guidelines. I’ve seen too many trauma centers delay writing up their protocols because they are waiting for a better paper to be published on this or that. Good luck! It’s not coming any time soon!

Bottom line: Hopefully, I’ve convinced you that we’ve got the nomenclature all wrong. What we really want are evidence-informed protocols, not evidence-based guidelines!

Home of the Trauma Professional's Blog

Do you want to get a daily email every time there’s a new post? See what I’m up to.

Click here to get details and subscribe!

[accua-form fid=”1″]

[mc4wp_form id=”2023″]